These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9721189)

  • 1. Recombinant human cytochrome P450 1B1 expression in Escherichia coli.
    Shimada T; Wunsch RM; Hanna IH; Sutter TR; Guengerich FP; Gillam EM
    Arch Biochem Biophys; 1998 Sep; 357(1):111-20. PubMed ID: 9721189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cytochrome P450 3A7 in Escherichia coli: effects of 5' modification and catalytic characterization of recombinant enzyme expressed in bicistronic format with NADPH-cytochrome P450 reductase.
    Gillam EM; Wunsch RM; Ueng YF; Shimada T; Reilly PE; Kamataki T; Guengerich FP
    Arch Biochem Biophys; 1997 Oct; 346(1):81-90. PubMed ID: 9328287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of NADPH-P450 reductase in the O-deethylation of 7-ethoxycoumarin by recombinant human cytochrome P450 1B1 variants in Escherichia coli.
    Shimada T; Tsumura F; Gillam EM; Guengerich FP; Inoue K
    Protein Expr Purif; 2000 Oct; 20(1):73-80. PubMed ID: 11035953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
    Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H
    Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of modified cytochrome P450 2C10 (2C9) in Escherichia coli, purification, and reconstitution of catalytic activity.
    Sandhu P; Baba T; Guengerich FP
    Arch Biochem Biophys; 1993 Nov; 306(2):443-50. PubMed ID: 8215449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of recombinant-expressed cytochrome P450 2C3 from Escherichia coli: 2C3 encodes the 6 beta-hydroxylase deficient form of P450 3b.
    Richardson TH; Hsu MH; Kronbach T; Barnes HJ; Chan G; Waterman MR; Kemper B; Johnson EF
    Arch Biochem Biophys; 1993 Jan; 300(1):510-6. PubMed ID: 8380971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a human cytochrome P450 1A1: rat NADPH-cytochrome P450 reductase fusion protein cDNA and expression in Escherichia coli, purification, and catalytic properties of the enzyme in bacterial cells and after purification.
    Chun YJ; Shimada T; Guengerich FP
    Arch Biochem Biophys; 1996 Jun; 330(1):48-58. PubMed ID: 8651703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of benzo[a]pyrene to trans-7,8-dihydroxy-7, 8-dihydrobenzo[a]pyrene by recombinant human cytochrome P450 1B1 and purified liver epoxide hydrolase.
    Shimada T; Gillam EM; Oda Y; Tsumura F; Sutter TR; Guengerich FP; Inoue K
    Chem Res Toxicol; 1999 Jul; 12(7):623-9. PubMed ID: 10409402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis.
    Chun YJ; Kim S; Kim D; Lee SK; Guengerich FP
    Cancer Res; 2001 Nov; 61(22):8164-70. PubMed ID: 11719446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of CYP3A9 gene expression by estrogen and catalytic studies using cytochrome P450 3A9 expressed in Escherichia coli.
    Wang H; Strobel HW
    Arch Biochem Biophys; 1997 Aug; 344(2):365-72. PubMed ID: 9264551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escherichia coli expression and characterization of cytochromes P450 2B11, 2B1, and 2B5.
    John GH; Hasler JA; He YA; Halpert JR
    Arch Biochem Biophys; 1994 Nov; 314(2):367-75. PubMed ID: 7979377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactivation of diesel exhaust particle extracts and their major nitrated polycyclic aromatic hydrocarbon components, 1-nitropyrene and dinitropyrenes, by human cytochromes P450 1A1, 1A2, and 1B1.
    Yamazaki H; Hatanaka N; Kizu R; Hayakawa K; Shimada N; Guengerich FP; Nakajima M; Yokoi T
    Mutat Res; 2000 Dec; 472(1-2):129-38. PubMed ID: 11113705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexpression of mammalian cytochrome P450 and reductase in Escherichia coli.
    Dong J; Porter TD
    Arch Biochem Biophys; 1996 Mar; 327(2):254-9. PubMed ID: 8619611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme.
    Gillam EM; Baba T; Kim BR; Ohmori S; Guengerich FP
    Arch Biochem Biophys; 1993 Aug; 305(1):123-31. PubMed ID: 8342945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human P450 forms 1A1, 1A2, and 1B1 catalyze the bioactivation of heterocyclic amine mutagens in Escherichia coli lacZ strains.
    Josephy PD; Batty SM; Boverhof DR
    Environ Mol Mutagen; 2001; 38(1):12-8. PubMed ID: 11473383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli.
    Yamazaki H; Nakamura M; Komatsu T; Ohyama K; Hatanaka N; Asahi S; Shimada N; Guengerich FP; Shimada T; Nakajima M; Yokoi T
    Protein Expr Purif; 2002 Apr; 24(3):329-37. PubMed ID: 11922748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of N-terminal modification of recombinant human cytochrome P450 1A2 on catalytic activity.
    Kim HJ; Lee SB; Guengerich FP; Park YI; Dong MS
    Xenobiotica; 2007 Apr; 37(4):356-65. PubMed ID: 17455110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of modified human cytochrome P450 1A1 in Escherichia coli: effects of 5' substitution, stabilization, purification, spectral characterization, and catalytic properties.
    Guo Z; Gillam EM; Ohmori S; Tukey RH; Guengerich FP
    Arch Biochem Biophys; 1994 Aug; 312(2):436-46. PubMed ID: 8037457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of modified human cytochrome P450 1A2 in Escherichia coli: stabilization, purification, spectral characterization, and catalytic activities of the enzyme.
    Sandhu P; Guo Z; Baba T; Martin MV; Tukey RH; Guengerich FP
    Arch Biochem Biophys; 1994 Feb; 309(1):168-77. PubMed ID: 8117105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase.
    Dong MS; Yamazaki H; Guo Z; Guengerich FP
    Arch Biochem Biophys; 1996 Mar; 327(1):11-9. PubMed ID: 8615680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.